Published November 11, 2020
format_quote In all my 20-some-odd years of [investing], Monday was one of the most interesting days I’ve witnessed on the back of the Pfizer vaccine news.
In all my 20-some-odd years of [investing], Monday was one of the most interesting days I’ve witnessed on the back of the Pfizer vaccine news.
An end to election uncertainty and encouraging COVID-19 vaccine news sent stocksA financial instrument giving the holder a proportion of the ownership and earnings of a company. surging. But typically, it’s not news, but corporate earnings results that drive the stockA financial instrument giving the holder a proportion of the ownership and earnings of a company. market. How are these recent blockbuster events likely to impact bottom lines and outlooks as companies grapple with renewed coronavirus challenges?
Join Director of Research Jeff DeMaso and DividendA cash payment to investors who own stock in the company. Income Portfolio Managers Charlie Toole and Steve Johnson as they answer the following questions:
For more on the election, a promising vaccine and the earnings picture, click above to listen now!
This podcast is for informational purposes only. It is not intended as financial, legal, tax or insurance advice even though these topics may be discussed. Information and events addressed in this podcast, as well as the job titles, job functions and employment of the podcast’s participants with respect to Adviser Investments, LLC may have changed since this podcast was released. Personalized tax advice and tax return preparation is available through a separate, written engagement agreement with Adviser Investments Tax Solutions..
The Adviser You Can Talk To Podcast is a trademark of Adviser Investments, LLC. Registration pending.
© 2023 Adviser Investments, LLC. All Rights Reserved.
Investment insights.Right in your inbox.
Adviser Investments' logo is a registered trademark of Adviser Investments, LLC.